高血压与脑小血管病中的血管IV型胶原蛋白
研究在老年人、灵长类及遗传性高血压大鼠中检测血管IV型胶原蛋白免疫标记,发现老年人脑小动脉IV型胶原蛋白与影像学脑小血管病严重程度呈负相关(ρ=-0.427,P=0.005),但与高血压史无关;年轻和老年灵长类中老年血压正常组脑IV型胶原蛋白高于年轻血压正常组(P=0.029),遗传性高血压大鼠与血压正常大鼠无差异。
要点
- 老年人脑小动脉IV型胶原蛋白与影像学脑小血管病严重程度呈负相关(ρ=-0.427,P=0.005)。
- 老年人血管IV型胶原蛋白减少与I型和III型纤维状胶原积累相关。
- 高血压可能不通过导致脑血管IV型胶原蛋白积累来发挥作用。
核心结论
- 跨物种数据提示散发性脑小血管病存在动脉IV型胶原蛋白不足而非过多,并伴有纤维状胶原沉积的基质重塑。
- 高血压作为脑小血管病主要风险因素,并不通过引起脑血管IV型胶原蛋白积累发挥作用。
研究设计与样本
- 量化52例(21女/31男,年龄82.8±6.95岁)阿尔茨海默病理轻微的老年人小动脉血管IV型胶原蛋白免疫标记。
- 研究年轻(6.2-8.3岁)和老年(17.0-22.7岁)灵长类(恒河猴)档案组织,比较慢性高血压动物(18个月主动脉狭窄)与血压正常动物。
- 比较遗传性高血压与血压正常大鼠(10-12个月龄)。
主要发现
- 老年人脑小动脉IV型胶原蛋白免疫标记与影像学脑小血管病严重程度呈负相关(ρ=-0.427,P=0.005),与高血压史无关。
- 一般线性模型确认较低IV型胶原蛋白与影像学脑小血管病负相关(P<0.017),纳入年龄协变量及临床高血压(P<0.030)或神经病理脑小血管病诊断(P<0.022)为固定因子。
- 免疫金电子显微镜显示血管IV型胶原蛋白减少伴随I型和III型纤维状胶原积累。
- 年轻和老年灵长类中,老年血压正常动物脑IV型胶原蛋白高于年轻血压正常动物(P=0.029),但与高血压无关。
- 遗传性高血压大鼠与血压正常大鼠动脉IV型胶原蛋白无差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cerebral small vessel disease (SVD) is common in older people and causes lacunar stroke and vascular cognitive impairment. Risk factors include old age, hypertension and variants in the genes COL4A1/COL4A2 encoding collagen alpha-1(IV) and alpha-2(IV), here termed collagen-IV, which are core components of the basement membrane. We tested the hypothesis that increased vascular collagen-IV associates with clinical hypertension and with SVD in older persons and with chronic hypertension in young and aged primates and genetically hypertensive rats. METHODS: We quantified vascular collagen-IV immunolabeling in small arteries in a cohort of older persons with minimal Alzheimer pathology (N=52; 21F/31M, age 82.8±6.95 years). We also studied archive tissue from young (age range 6.2-8.3 years) and older (17.0-22.7 years) primates (M mulatta) and compared chronically hypertensive animals (18 months aortic stenosis) with normotensives. We also compared genetically hypertensive and normotensive rats (aged 10-12 months). RESULTS: Collagen-IV immunolabeling in cerebral small arteries of older persons was negatively associated with radiological SVD severity (ρ: -0.427, P=0.005) but was not related to history of hypertension. General linear models confirmed the negative association of lower collagen-IV with radiological SVD (P<0.017), including age as a covariate and either clinical hypertension (P<0.030) or neuropathological SVD diagnosis (P<0.022) as fixed factors. Reduced vascular collagen-IV was accompanied by accumulation of fibrillar collagens (types I and III) as indicated by immunogold electron microscopy. In young and aged primates, brain collagen-IV was elevated in older normotensive relative to young normotensive animals (P=0.029) but was not associated with hypertension. Genetically hypertensive rats did not differ from normotensive rats in terms of arterial collagen-IV. CONCLUSIONS: Our cross-species data provide novel insight into sporadic SVD pathogenesis, supporting insufficient (rather than excessive) arterial collagen-IV in SVD, accompanied by matrix remodeling with elevated fibrillar collagen deposition. They also indicate that hypertension, a major risk factor for SVD, does not act by causing accumulation of brain vascular collagen-IV.
引用
- Kumar AA, Yeo N, Whittaker M, et al. Vascular Collagen Type-IV in Hypertension and Cerebral Small Vessel Disease. Stroke. 2022. PMID: 36205142. doi:10.1161/STROKEAHA.122.037761
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。